Quarterly report pursuant to Section 13 or 15(d)

Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail)

v3.5.0.2
Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:        
Net loss $ (39,822) $ (13,934) $ (135,657) $ (10,156)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 36,317 38,351 72,131 78,890
Accretion of contingent consideration     419 306
(Gain) loss on disposition of assets 2 138 62 (2,303)
Deferred income tax expense (benefit)     59,305 (17,126)
Expenses not requiring cash     (5,226) (5,308)
Equity in net earnings of subsidiaries 0 0 0 0
Accounts and notes receivable     22,319 39,683
Accrued income taxes     (3,985) (1,236)
Other assets     (2,992) (7,352)
Accounts payable and accrued liabilities     (6,862) 14,763
Net cash provided by operating activities     602 103,093
Cash flows from investing activities:        
Capital expenditures     (16,257) (54,605)
Proceeds from the sale of assets     1,387 288
Proceeds from insurance settlements     0 2,500
Payments to Acquire Businesses, Net of Cash Acquired     0 10,431
Net cash used in investing activities     (14,870) (62,248)
Cash flows from financing activities:        
Repayments of long-term debt       (30,000)
Paydown on term note     0 (30,000)
Payment of debt issuance costs     0 (1,359)
Payment for noncontrolling interest     3,375 0
Payments of contingent consideration     (6,000) 0
Excess tax benefit from stock-based compensation     (1,617) (999)
Intercompany advances, net     0 0
Net cash used in financing activities     (10,992) (32,358)
Net increase (decrease) in cash and cash equivalents     (25,260) 8,487
Cash and cash equivalents, beginning of year   116,943 134,294 108,456
Cash and cash equivalents, end of period 109,034 116,943 109,034 116,943
Provision for reduction in carrying value of certain assets 0 2,316 0 2,316
Loss on debt modification     (1,088) 0
Parent [Member]        
Cash flows from operating activities:        
Net loss (39,824) (14,029) (135,657) (10,807)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 0 0 0 0
Accretion of contingent consideration     0 0
(Gain) loss on disposition of assets 0 0 0 0
Deferred income tax expense (benefit)     (49,167) 22,414
Expenses not requiring cash     (2,693) (4,039)
Equity in net earnings of subsidiaries 24,568 8,392 40,793 (597)
Accounts and notes receivable     0 0
Accrued income taxes     21,711 2,146
Other assets     (103,035) (77,427)
Accounts payable and accrued liabilities     3,281 29
Net cash provided by operating activities     (119,959) (105,031)
Cash flows from investing activities:        
Capital expenditures     0 0
Proceeds from the sale of assets     0 0
Proceeds from insurance settlements       0
Payments to Acquire Businesses, Net of Cash Acquired       0
Net cash used in investing activities     0 0
Cash flows from financing activities:        
Repayments of long-term debt       (30,000)
Payment of debt issuance costs       (1,359)
Payment for noncontrolling interest     3,375  
Payments of contingent consideration     0  
Excess tax benefit from stock-based compensation     (1,617) (999)
Intercompany advances, net     106,246 142,814
Net cash used in financing activities     101,254 110,456
Net increase (decrease) in cash and cash equivalents     (18,705) 5,425
Cash and cash equivalents, beginning of year   42,153 73,985 36,728
Cash and cash equivalents, end of period 55,280   55,280  
Provision for reduction in carrying value of certain assets       0
Loss on debt modification     1,088  
Guarantor [Member]        
Cash flows from operating activities:        
Net loss (16,502) (7,187) (30,816) (4,868)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 23,314 23,958 46,439 47,268
Accretion of contingent consideration     419 0
(Gain) loss on disposition of assets (209) 6 (153) (45)
Deferred income tax expense (benefit)     (9,569) (6,574)
Expenses not requiring cash     282 (441)
Equity in net earnings of subsidiaries 0 0 0 0
Accounts and notes receivable     7,755 27,778
Accrued income taxes     (17,830) 229
Other assets     102,496 59,964
Accounts payable and accrued liabilities     (5,737) 14,890
Net cash provided by operating activities     111,860 152,231
Cash flows from investing activities:        
Capital expenditures     (7,499) (37,794)
Proceeds from the sale of assets     121 82
Proceeds from insurance settlements       0
Payments to Acquire Businesses, Net of Cash Acquired       10,431
Net cash used in investing activities     (7,378) (48,143)
Cash flows from financing activities:        
Repayments of long-term debt       0
Payment of debt issuance costs       0
Payment for noncontrolling interest     0  
Payments of contingent consideration     (6,000)  
Excess tax benefit from stock-based compensation     0 0
Intercompany advances, net     (100,144) (97,138)
Net cash used in financing activities     (106,144) (97,138)
Net increase (decrease) in cash and cash equivalents     (1,662) 6,950
Cash and cash equivalents, beginning of year   20,496 13,854 13,546
Cash and cash equivalents, end of period 12,192   12,192  
Provision for reduction in carrying value of certain assets       0
Loss on debt modification     0  
Non-Guarantor [Member]        
Cash flows from operating activities:        
Net loss (8,064) (1,110) (9,977) 6,116
Adjustments to reconcile net income (loss)        
Depreciation and amortization 13,003 14,393 25,692 31,622
Accretion of contingent consideration     0 306
(Gain) loss on disposition of assets 211 132 215 (2,258)
Deferred income tax expense (benefit)     (569) 1,286
Expenses not requiring cash     7,637 (828)
Equity in net earnings of subsidiaries 0 0 0 0
Accounts and notes receivable     14,564 11,905
Accrued income taxes     (7,866) (3,611)
Other assets     (2,453) 10,111
Accounts payable and accrued liabilities     (4,406) (156)
Net cash provided by operating activities     8,701 55,893
Cash flows from investing activities:        
Capital expenditures     (8,758) (16,811)
Proceeds from the sale of assets     1,266 206
Proceeds from insurance settlements       2,500
Payments to Acquire Businesses, Net of Cash Acquired       0
Net cash used in investing activities     (7,492) (14,105)
Cash flows from financing activities:        
Repayments of long-term debt       0
Payment of debt issuance costs       0
Payment for noncontrolling interest     0  
Payments of contingent consideration     0  
Excess tax benefit from stock-based compensation     0 0
Intercompany advances, net     (6,102) (45,676)
Net cash used in financing activities     (6,102) (45,676)
Net increase (decrease) in cash and cash equivalents     (4,893) (3,888)
Cash and cash equivalents, beginning of year   54,294 46,455 58,182
Cash and cash equivalents, end of period 41,562   41,562  
Provision for reduction in carrying value of certain assets   2,316   (2,316)
Loss on debt modification     0  
Consolidation, Eliminations [Member]        
Cash flows from operating activities:        
Net loss 24,568 8,392 40,793 (597)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 0 0 0 0
Accretion of contingent consideration     0 0
(Gain) loss on disposition of assets 0 0 0 0
Deferred income tax expense (benefit)     0 0
Expenses not requiring cash     0 0
Equity in net earnings of subsidiaries (24,568) (8,392) (40,793) 597
Accounts and notes receivable     0 0
Accrued income taxes     0 0
Other assets     0 0
Accounts payable and accrued liabilities     0 0
Net cash provided by operating activities     0 0
Cash flows from investing activities:        
Capital expenditures     0 0
Proceeds from the sale of assets     0 0
Proceeds from insurance settlements       0
Payments to Acquire Businesses, Net of Cash Acquired       0
Net cash used in investing activities     0 0
Cash flows from financing activities:        
Repayments of long-term debt       0
Payment of debt issuance costs       0
Payment for noncontrolling interest     0  
Payments of contingent consideration     0  
Excess tax benefit from stock-based compensation     0 0
Intercompany advances, net     0 0
Net cash used in financing activities     0 0
Net increase (decrease) in cash and cash equivalents     0 0
Cash and cash equivalents, beginning of year   $ 0 0 0
Cash and cash equivalents, end of period $ 0   0  
Provision for reduction in carrying value of certain assets       $ 0
Loss on debt modification     $ 0